Citation Impact
Citing Papers
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Heparin-Protein Interactions
2002 Standout
Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2
1994 StandoutNobel
Inactivated poliovirus vaccine: past and present experience
1996
The FGF family: biology, pathophysiology and therapy
2009 Standout
The antiviral activity of antibodies in vitro and in vivo
2001
Antigenic Sites of Coxsackievirus A9
1998
Engineered cell surfaces: fertile ground for molecular landscaping
1997 StandoutNobel
Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein
2000 StandoutNobel
Antibody recognition of picornaviruses and escape from neutralization: a structural view
1995
Complications of RNA Heterogeneity for the Engineering of Virus Vaccines and Antiviral Agents
1992
Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins
1990
Versatility of a vector for expressing foreign polypeptides at the surface of Gram-negative bacteria
1988
Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain
1996 StandoutNobel
Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: Structure of the empty capsid assembly intermediate at 2.9 Å resolution
1994
The 5′ noncoding region and virulence of poliovirus vaccine strains
1994
Poliovirus and poliomyelitis: A tale of guts, brains, and an accidental event
2005
Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213
1995 StandoutNobel
Neutralization antigenic sites on type Asia-1 foot-and-mouth disease virus defined by monoclonal antibody-resistant variants
1997
Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein
1996
Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase?
2009
The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line
2014
The Mutation Rate and Variability of Eukaryotic Viruses: An Analytical Review
1987
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease
1992
Sprouty proteins, masterminds of receptor tyrosine kinase signaling
2008
The Spot Technique: Synthesis and Screening of Peptide Macroarrays on Cellulose Membranes
2008 StandoutNobel
Coxsackievirus B3 clinical isolates and murine myocarditis
1996
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Myocarditis
2009 Standout
RNA virus evolution and the control of viral disease
1989
Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles
1990
The alphaviruses: gene expression, replication, and evolution
1994 Standout
Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
1987 StandoutNobel
Analysis of neutralizing epitopes on foot-and-mouth disease virus
1988
A Third-Generation Lentivirus Vector with a Conditional Packaging System
1998 Standout
Foot-and-Mouth Disease
2004 Standout
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.
1994
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Cross Talk between PML and p53 during Poliovirus Infection: Implications for Antiviral Defense
2006
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
1993 StandoutNobel
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus
2019 StandoutNobel
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA
1997 StandoutNobel
Summary of notifiable diseases--United States, 2002.
2004 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
RNA virus error catastrophe: Direct molecular test by using ribavirin
2001
Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1
1986
Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.
1992 StandoutNobel
Neutralization of HIV‐1: a paradox of humoral proportions
1991
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1
1995 StandoutNobel
Antigenic Variation and Resistance to Neutralization in Poliovirus Type 1
1985 Science
Patterns of integration of exogenous DNA sequences transfected into mammalian cells of primate and rodent origin
1986
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys.
1988
Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
1988
GENETICS OF POLIOVIRUS
1993
Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes
1994 StandoutNobel
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160
1992 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA
1996 StandoutNobel
Preventives Versus Treatments *
2015 StandoutNobel
A Poliovirus Neutralization Epitope Expressed on Hybrid Hepatitis B Surface Antigen Particles
1986 Science
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience
Correlates of Protection Induced by Vaccination
2010 Standout
Genetic determinants of Sindbis virus neuroinvasiveness
1997 StandoutNobel
Works of F. Horaud being referenced
Molecular Pathogenesis of Neural Lesions Induced by Poliovirus Type 1
1989
Albert B. Sabin and the Development of Oral Poliovaccine
1993
Poliovirus permissivity and specific receptor expression on human endothelial cells
1990
Construction and characterization of hybrid hepatitis B antigen particles carrying a poliovirus immunogen
1988
Comparative Expression of the Hepatitis B Surface Antigen Gene in Biochemically Transformed Human, Simian and Murine Cells
1985
Identification and characterization of a continuous neutralization epitope (C3) present on type 1 poliovirus.
1987
Polio vaccine: From empiricism and efficacyto scientific knowledge
1985
Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell
1993
Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
1985
A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice
1993
Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site
1986
Absence of viral sequences in the WHO-Vero Cell Bank. A collaborative study.
1992
Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature
1990
Antigenic and Molecular Properties of Type 3 Poliovirus Responsible for an Outbreak of Poliomyelitis in a Vaccinated Population
1986